View Future GrowthArtery Technology 過去の業績過去 基準チェック /56Artery Technologyは、平均年間35.2%の収益成長を遂げていますが、 Semiconductor業界の収益は、年間 減少しています。収益は、平均年間4.2% 43.1%収益成長率で 成長しています。 Artery Technologyの自己資本利益率は19.3%であり、純利益率は12.8%です。主要情報35.16%収益成長率33.16%EPS成長率Semiconductor 業界の成長19.89%収益成長率43.13%株主資本利益率19.27%ネット・マージン12.81%前回の決算情報30 Jun 2026最近の業績更新Reported Earnings • Aug 04Second quarter 2026 earnings released: EPS: NT$2.79 (vs NT$0.47 in 2Q 2025)Second quarter 2026 results: EPS: NT$2.79 (up from NT$0.47 in 2Q 2025). Revenue: NT$963.1m (up 102% from 2Q 2025). Net income: NT$174.6m (up NT$150.8m from 2Q 2025). Profit margin: 18% (up from 5.0% in 2Q 2025). The increase in margin was driven by higher revenue.Reported Earnings • Feb 11Full year 2025 earnings released: EPS: NT$2.08 (vs NT$1.67 in FY 2024)Full year 2025 results: EPS: NT$2.08 (up from NT$1.67 in FY 2024). Revenue: NT$1.67b (up 1.9% from FY 2024). Net income: NT$106.7m (up 25% from FY 2024). Profit margin: 6.4% (up from 5.2% in FY 2024).すべての更新を表示Recent updatesReported Earnings • Aug 04Second quarter 2026 earnings released: EPS: NT$2.79 (vs NT$0.47 in 2Q 2025)Second quarter 2026 results: EPS: NT$2.79 (up from NT$0.47 in 2Q 2025). Revenue: NT$963.1m (up 102% from 2Q 2025). Net income: NT$174.6m (up NT$150.8m from 2Q 2025). Profit margin: 18% (up from 5.0% in 2Q 2025). The increase in margin was driven by higher revenue.Valuation Update With 7 Day Price Move • Jul 28Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to NT$178, the stock trades at a trailing P/E ratio of 69.2x. Average trailing P/E is 42x in the Semiconductor industry in Taiwan.Buy Or Sell Opportunity • Jul 14Now 29% overvalued after recent price riseOver the last 90 days, the stock has risen 57% to NT$212. The fair value is estimated to be NT$165, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last year. Earnings per share has grown by 60%.Valuation Update With 7 Day Price Move • Jul 08Investor sentiment improves as stock rises 33%After last week's 33% share price gain to NT$189, the stock trades at a trailing P/E ratio of 73.4x. Average trailing P/E is 50x in the Semiconductor industry in Taiwan.Valuation Update With 7 Day Price Move • Jun 23Investor sentiment improves as stock rises 19%After last week's 19% share price gain to NT$160, the stock trades at a trailing P/E ratio of 62.2x. Average trailing P/E is 51x in the Semiconductor industry in Taiwan.Valuation Update With 7 Day Price Move • Jun 03Investor sentiment improves as stock rises 20%After last week's 20% share price gain to NT$140, the stock trades at a trailing P/E ratio of 54.1x. Average trailing P/E is 46x in the Semiconductor industry in Taiwan.Valuation Update With 7 Day Price Move • Apr 30Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to NT$119, the stock trades at a trailing P/E ratio of 69.3x. Average trailing P/E is 44x in the Semiconductor industry in Taiwan.Valuation Update With 7 Day Price Move • Apr 14Investor sentiment improves as stock rises 18%After last week's 18% share price gain to NT$128, the stock trades at a trailing P/E ratio of 74.3x. Average trailing P/E is 41x in the Semiconductor industry in Taiwan.Valuation Update With 7 Day Price Move • Mar 26Investor sentiment deteriorates as stock falls 22%After last week's 22% share price decline to NT$124, the stock trades at a trailing P/E ratio of 72.3x. Average trailing P/E is 38x in the Semiconductor industry in Taiwan.Valuation Update With 7 Day Price Move • Mar 04Investor sentiment improves as stock rises 20%After last week's 20% share price gain to NT$93.20, the stock trades at a trailing P/E ratio of 54.3x. Average trailing P/E is 36x in the Semiconductor industry in Taiwan.Board Change • Feb 26No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. No independent directors (3 non-independent directors). Chief Strategy Officer & Chairman Steve Wang was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Feb 16Investor sentiment improves as stock rises 21%After last week's 21% share price gain to NT$58.70, the stock trades at a trailing P/E ratio of 34.2x. Average trailing P/E is 34x in the Semiconductor industry in Taiwan.Reported Earnings • Feb 11Full year 2025 earnings released: EPS: NT$2.08 (vs NT$1.67 in FY 2024)Full year 2025 results: EPS: NT$2.08 (up from NT$1.67 in FY 2024). Revenue: NT$1.67b (up 1.9% from FY 2024). Net income: NT$106.7m (up 25% from FY 2024). Profit margin: 6.4% (up from 5.2% in FY 2024).お知らせ • Feb 10Artery Technology Corporation, Annual General Meeting, May 26, 2026Artery Technology Corporation, Annual General Meeting, May 26, 2026. Location: 1 floor no,1, chin shan 8th st., east district, hsinchu city Taiwanお知らせ • Jan 30Artery Technology Corporation has completed an IPO in the amount of TWD 397.70745 million.Artery Technology Corporation has completed an IPO in the amount of TWD 397.70745 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 7,919,000 Price\Range: TWD 38.55 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 3,081,000 Price\Range: TWD 30 Transaction Features: Sponsor Backed OfferingBoard Change • Jan 29No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. No independent directors (3 non-independent directors). Chief Strategy Officer & Chairman Steve Wang was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.収支内訳Artery Technology の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史TPEX:6907 収益、費用、利益 ( )TWD Millions日付収益収益G+A経費研究開発費30 Jun 262,43231223034131 Mar 261,94516121528231 Dec 251,66610719925130 Sep 251,63611120224730 Jun 251,69910519525831 Mar 251,6959719024231 Dec 241,6358517822931 Dec 231,014-7615917531 Dec 221,368140171225質の高い収益: 6907は 高品質の収益 を持っています。利益率の向上: 6907の現在の純利益率 (12.8%)は、昨年(6.2%)よりも高くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: 6907の収益は過去 5 年間で年間35.2%増加しました。成長の加速: 6907の過去 1 年間の収益成長率 ( 195.9% ) は、5 年間の平均 ( 年間35.2%を上回っています。収益対業界: 6907の過去 1 年間の収益成長率 ( 195.9% ) はSemiconductor業界41%を上回りました。株主資本利益率高いROE: 6907の 自己資本利益率 ( 19.3% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YSemiconductors 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/08/20 02:40終値2026/08/20 00:00収益2026/06/30年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Artery Technology Corporation 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Reported Earnings • Aug 04Second quarter 2026 earnings released: EPS: NT$2.79 (vs NT$0.47 in 2Q 2025)Second quarter 2026 results: EPS: NT$2.79 (up from NT$0.47 in 2Q 2025). Revenue: NT$963.1m (up 102% from 2Q 2025). Net income: NT$174.6m (up NT$150.8m from 2Q 2025). Profit margin: 18% (up from 5.0% in 2Q 2025). The increase in margin was driven by higher revenue.
Reported Earnings • Feb 11Full year 2025 earnings released: EPS: NT$2.08 (vs NT$1.67 in FY 2024)Full year 2025 results: EPS: NT$2.08 (up from NT$1.67 in FY 2024). Revenue: NT$1.67b (up 1.9% from FY 2024). Net income: NT$106.7m (up 25% from FY 2024). Profit margin: 6.4% (up from 5.2% in FY 2024).
Reported Earnings • Aug 04Second quarter 2026 earnings released: EPS: NT$2.79 (vs NT$0.47 in 2Q 2025)Second quarter 2026 results: EPS: NT$2.79 (up from NT$0.47 in 2Q 2025). Revenue: NT$963.1m (up 102% from 2Q 2025). Net income: NT$174.6m (up NT$150.8m from 2Q 2025). Profit margin: 18% (up from 5.0% in 2Q 2025). The increase in margin was driven by higher revenue.
Valuation Update With 7 Day Price Move • Jul 28Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to NT$178, the stock trades at a trailing P/E ratio of 69.2x. Average trailing P/E is 42x in the Semiconductor industry in Taiwan.
Buy Or Sell Opportunity • Jul 14Now 29% overvalued after recent price riseOver the last 90 days, the stock has risen 57% to NT$212. The fair value is estimated to be NT$165, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last year. Earnings per share has grown by 60%.
Valuation Update With 7 Day Price Move • Jul 08Investor sentiment improves as stock rises 33%After last week's 33% share price gain to NT$189, the stock trades at a trailing P/E ratio of 73.4x. Average trailing P/E is 50x in the Semiconductor industry in Taiwan.
Valuation Update With 7 Day Price Move • Jun 23Investor sentiment improves as stock rises 19%After last week's 19% share price gain to NT$160, the stock trades at a trailing P/E ratio of 62.2x. Average trailing P/E is 51x in the Semiconductor industry in Taiwan.
Valuation Update With 7 Day Price Move • Jun 03Investor sentiment improves as stock rises 20%After last week's 20% share price gain to NT$140, the stock trades at a trailing P/E ratio of 54.1x. Average trailing P/E is 46x in the Semiconductor industry in Taiwan.
Valuation Update With 7 Day Price Move • Apr 30Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to NT$119, the stock trades at a trailing P/E ratio of 69.3x. Average trailing P/E is 44x in the Semiconductor industry in Taiwan.
Valuation Update With 7 Day Price Move • Apr 14Investor sentiment improves as stock rises 18%After last week's 18% share price gain to NT$128, the stock trades at a trailing P/E ratio of 74.3x. Average trailing P/E is 41x in the Semiconductor industry in Taiwan.
Valuation Update With 7 Day Price Move • Mar 26Investor sentiment deteriorates as stock falls 22%After last week's 22% share price decline to NT$124, the stock trades at a trailing P/E ratio of 72.3x. Average trailing P/E is 38x in the Semiconductor industry in Taiwan.
Valuation Update With 7 Day Price Move • Mar 04Investor sentiment improves as stock rises 20%After last week's 20% share price gain to NT$93.20, the stock trades at a trailing P/E ratio of 54.3x. Average trailing P/E is 36x in the Semiconductor industry in Taiwan.
Board Change • Feb 26No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. No independent directors (3 non-independent directors). Chief Strategy Officer & Chairman Steve Wang was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Feb 16Investor sentiment improves as stock rises 21%After last week's 21% share price gain to NT$58.70, the stock trades at a trailing P/E ratio of 34.2x. Average trailing P/E is 34x in the Semiconductor industry in Taiwan.
Reported Earnings • Feb 11Full year 2025 earnings released: EPS: NT$2.08 (vs NT$1.67 in FY 2024)Full year 2025 results: EPS: NT$2.08 (up from NT$1.67 in FY 2024). Revenue: NT$1.67b (up 1.9% from FY 2024). Net income: NT$106.7m (up 25% from FY 2024). Profit margin: 6.4% (up from 5.2% in FY 2024).
お知らせ • Feb 10Artery Technology Corporation, Annual General Meeting, May 26, 2026Artery Technology Corporation, Annual General Meeting, May 26, 2026. Location: 1 floor no,1, chin shan 8th st., east district, hsinchu city Taiwan
お知らせ • Jan 30Artery Technology Corporation has completed an IPO in the amount of TWD 397.70745 million.Artery Technology Corporation has completed an IPO in the amount of TWD 397.70745 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 7,919,000 Price\Range: TWD 38.55 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 3,081,000 Price\Range: TWD 30 Transaction Features: Sponsor Backed Offering
Board Change • Jan 29No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. No independent directors (3 non-independent directors). Chief Strategy Officer & Chairman Steve Wang was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.